NEXTBIOMEDICAL Co., Ltd.
Founded in 2014 and listed on KOSDAQ in 2024, NEXTBIOMEDICAL develops endoscopic hemostats and vascular embolization microspheres.
Price
Change
Market cap
Regulatory approvals
data.go.kr · openFDA24 Korean MFDS device approvals · 2015–2025 / 2 US FDA 510(k) · 2022–2024
- MFDSEmbolization implant inserter, intervascular2025-11-19Product approval · Class 3제허 25-781 호
- MFDSEmbolization implant inserter, intervascular2025-07-28Product approval · Class 3제허 25-515 호
- FDANexpowder2024-11-27
- MFDSDressing, absorbable, wound, synthetic polymer2024-11-26Product approval · Class 4제허 24-837 호
- FDANexpowder2022-09-16
- MFDSDressing, absorbable, wound, synthetic polymer2021-12-08Product approval · Class 4제허 21-990 호
- MFDSEmbolization implant inserter, intervascularRevoked2020-12-10Product approval · Class 3제허 20-1064 호
- MFDSStent, duodenalRevoked2020-10-15Product approval · Class 3제허 20-887 호
- MFDSStent, colonRevoked2020-10-15Product approval · Class 3제허 20-886 호
- MFDSEmbolization implant inserter, intervascular2019-06-27Product approval · Class 3제허 19-412 호
- MFDSStent, colonRevoked2018-04-05Product approval · Class 3제허 18-229 호
- MFDSOesophageal stentRevoked2018-04-05Product approval · Class 3제허 18-228 호
Show 14 more
- MFDSStent, duodenalRevoked2018-04-02Product approval · Class 3제허 18-216 호
- MFDSBiliary stentRevoked2018-04-02Product approval · Class 3제허 18-215 호
- MFDSStent, duodenalRevoked2018-03-14Product approval · Class 3제허 18-174 호
- MFDSEndotherapy cannula, single-use2018-02-23Product approval · Class 2제인 18-4140 호
- MFDSDressing, absorbable, wound, synthetic polymer2018-01-09Product approval · Class 4제허 18-14 호
- MFDSStent, colonRevoked2016-07-04Product approval · Class 3제허 16-470 호
- MFDSStent, colonRevoked2016-07-04Product approval · Class 3제허 16-469 호
- MFDSStent, duodenalRevoked2016-06-21Product approval · Class 3제허 16-438 호
- MFDSBiliary stentRevoked2016-02-25Product approval · Class 3제허 16-144 호
- MFDSOesophageal stentRevoked2016-02-18Product approval · Class 3제허 16-123 호
- MFDSENT powder applicatorRevoked2016-02-11Product approval · Class 1수신 16-370 호
- MFDSENT powder applicator2015-11-10Product approval · Class 1제신 15-380 호
- MFDSBiliary stentRevoked2015-11-02Product approval · Class 3제허 15-1539 호
- MFDSOesophageal stentRevoked2015-11-02Product approval · Class 3제허 15-1540 호
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.
Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.
Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.
Spun off from Jeil Pharm Holdings in 2017, Jeil Pharmaceutical has licensed out its GERD drug Zastaprazan (Jaqubo) to multiple overseas partners.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
KOSDAQ-listed manufacturer of diagnostic X-ray imaging systems and core components such as generators and tubes.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition